173 related articles for article (PubMed ID: 31526207)
1. Effects of ketamine in patients with treatment-refractory generalized anxiety and social anxiety disorders: Exploratory double-blind psychoactive-controlled replication study.
Glue P; Neehoff S; Sabadel A; Broughton L; Le Nedelec M; Shadli S; McNaughton N; Medlicott NJ
J Psychopharmacol; 2020 Mar; 34(3):267-272. PubMed ID: 31526207
[TBL] [Abstract][Full Text] [Related]
2. Ketamine's dose-related effects on anxiety symptoms in patients with treatment refractory anxiety disorders.
Glue P; Medlicott NJ; Harland S; Neehoff S; Anderson-Fahey B; Le Nedelec M; Gray A; McNaughton N
J Psychopharmacol; 2017 Oct; 31(10):1302-1305. PubMed ID: 28441895
[TBL] [Abstract][Full Text] [Related]
3. Ascending-Dose Study of Controlled-Release Ketamine Tablets in Healthy Volunteers: Pharmacokinetics, Pharmacodynamics, Safety, and Tolerability.
Glue P; Medlicott NJ; Surman P; Lam F; Hung N; Hung CT
J Clin Pharmacol; 2020 Jun; 60(6):751-757. PubMed ID: 32065415
[TBL] [Abstract][Full Text] [Related]
4. Ketamine Effects on EEG during Therapy of Treatment-Resistant Generalized Anxiety and Social Anxiety.
Shadli SM; Kawe T; Martin D; McNaughton N; Neehoff S; Glue P
Int J Neuropsychopharmacol; 2018 Aug; 21(8):717-724. PubMed ID: 29718262
[TBL] [Abstract][Full Text] [Related]
5. Safety and efficacy of maintenance ketamine treatment in patients with treatment-refractory generalised anxiety and social anxiety disorders.
Glue P; Neehoff SM; Medlicott NJ; Gray A; Kibby G; McNaughton N
J Psychopharmacol; 2018 Jun; 32(6):663-667. PubMed ID: 29561204
[TBL] [Abstract][Full Text] [Related]
6. Effect of ketamine dose on self-rated dissociation in patients with treatment refractory anxiety disorders.
Castle C; Gray A; Neehoff S; Glue P
J Psychopharmacol; 2017 Oct; 31(10):1306-1311. PubMed ID: 28922961
[TBL] [Abstract][Full Text] [Related]
7. Ketamine for treatment-resistant major depressive disorder: Double-blind active-controlled crossover study.
Glue P; Neehoff S; Beaglehole B; Shadli S; McNaughton N; Hughes-Medlicott NJ
J Psychopharmacol; 2024 Feb; 38(2):162-167. PubMed ID: 38293803
[TBL] [Abstract][Full Text] [Related]
8. Safety and efficacy of extended release ketamine tablets in patients with treatment-resistant depression and anxiety: open label pilot study.
Glue P; Medlicott NJ; Neehoff S; Surman P; Lam F; Hung N; Hung CT
Ther Adv Psychopharmacol; 2020; 10():2045125320922474. PubMed ID: 32523677
[TBL] [Abstract][Full Text] [Related]
9. Acute Dissociation and Ketamine's Antidepressant and Anti-Suicidal Ideation Effects in a Midazolam-Controlled Trial.
Sajid S; Galfalvy HC; Keilp JG; Burke AK; Mann JJ; Grunebaum MF
Int J Neuropsychopharmacol; 2024 Apr; 27(4):. PubMed ID: 38573154
[TBL] [Abstract][Full Text] [Related]
10. Anxiolytic effects of acute and maintenance ketamine, as assessed by the Fear Questionnaire subscales and the Spielberger State Anxiety Rating Scale.
Truppman Lattie D; Nehoff H; Neehoff S; Gray A; Glue P
J Psychopharmacol; 2021 Feb; 35(2):137-141. PubMed ID: 32900266
[TBL] [Abstract][Full Text] [Related]
11. Influence of formulation and route of administration on ketamine's safety and tolerability: systematic review.
Glue P; Russell B; Medlicott NJ
Eur J Clin Pharmacol; 2021 May; 77(5):671-676. PubMed ID: 33210159
[TBL] [Abstract][Full Text] [Related]
12. Efficacy and safety of ketamine in the management of anxiety and anxiety spectrum disorders: a review of the literature.
Banov MD; Young JR; Dunn T; Szabo ST
CNS Spectr; 2020 Jun; 25(3):331-342. PubMed ID: 31339086
[TBL] [Abstract][Full Text] [Related]
13. Midazolam attenuates ketamine-induced abnormal perception and thought process but not mood changes.
Suzuki M; Tsueda K; Lansing PS; Tolan MM; Fuhrman TM; Sheppard RA; Hurst HE; Lippmann SB
Can J Anaesth; 2000 Sep; 47(9):866-74. PubMed ID: 10989856
[TBL] [Abstract][Full Text] [Related]
14. Ketamine treatment for refractory anxiety: A systematic review.
Tully JL; Dahlén AD; Haggarty CJ; Schiöth HB; Brooks S
Br J Clin Pharmacol; 2022 Oct; 88(10):4412-4426. PubMed ID: 35510346
[TBL] [Abstract][Full Text] [Related]
15. Does adjunctive midazolam reduce recovery agitation after ketamine sedation for pediatric procedures? A randomized, double-blind, placebo-controlled trial.
Sherwin TS; Green SM; Khan A; Chapman DS; Dannenberg B
Ann Emerg Med; 2000 Mar; 35(3):229-38. PubMed ID: 10692189
[TBL] [Abstract][Full Text] [Related]
16. A transdiagnostic systematic review and meta-analysis of ketamine's anxiolytic effects.
Hartland H; Mahdavi K; Jelen LA; Strawbridge R; Young AH; Alexander L
J Psychopharmacol; 2023 Aug; 37(8):764-774. PubMed ID: 37005739
[TBL] [Abstract][Full Text] [Related]
17. Plasma brain derived neurotrophic factor (BDNF) and response to ketamine in treatment-resistant depression.
Haile CN; Murrough JW; Iosifescu DV; Chang LC; Al Jurdi RK; Foulkes A; Iqbal S; Mahoney JJ; De La Garza R; Charney DS; Newton TF; Mathew SJ
Int J Neuropsychopharmacol; 2014 Feb; 17(2):331-6. PubMed ID: 24103211
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of intravenous ketamine for treatment of chronic posttraumatic stress disorder: a randomized clinical trial.
Feder A; Parides MK; Murrough JW; Perez AM; Morgan JE; Saxena S; Kirkwood K; Aan Het Rot M; Lapidus KA; Wan LB; Iosifescu D; Charney DS
JAMA Psychiatry; 2014 Jun; 71(6):681-8. PubMed ID: 24740528
[TBL] [Abstract][Full Text] [Related]
19. A Double-Blind, Randomized, Placebo-Controlled, Dose-Frequency Study of Intravenous Ketamine in Patients With Treatment-Resistant Depression.
Singh JB; Fedgchin M; Daly EJ; De Boer P; Cooper K; Lim P; Pinter C; Murrough JW; Sanacora G; Shelton RC; Kurian B; Winokur A; Fava M; Manji H; Drevets WC; Van Nueten L
Am J Psychiatry; 2016 Aug; 173(8):816-26. PubMed ID: 27056608
[TBL] [Abstract][Full Text] [Related]
20. Daily oral ketamine for the treatment of depression and anxiety in patients receiving hospice care: a 28-day open-label proof-of-concept trial.
Irwin SA; Iglewicz A; Nelesen RA; Lo JY; Carr CH; Romero SD; Lloyd LS
J Palliat Med; 2013 Aug; 16(8):958-65. PubMed ID: 23805864
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
